DementiaPeptides.ca

Why this name

Peptides sit at the centre of how neurodegeneration is studied — amyloid-beta is itself a peptide fragment, and peptide chemistry runs through much of the diagnostic and investigational work around cognitive decline. Pairing that with dementia produces a name that states a research territory rather than a product, which is exactly the register serious groups in this space want.

Canada's .ca extension signals institutional footing: a university lab, a CIHR-funded consortium, a Canadian biotech, or a national patient and caregiver information project. Names built from initialisms mean nothing outside the group that chose them, and cheerful brand coinages sit poorly beside peer-reviewed work. This phrase tells a grant reviewer, a clinician, and a family member the same thing in the same three words.

Well suited to

• Canadian neurodegeneration research lab or consortium
• Peptide chemistry biotech focused on cognitive decline
• Clinical trial recruitment and registry site
• Caregiver and patient science-literacy resource

Ideal owner A Canadian research institute or neuroscience-focused biotech.